Abstract

It was generally accepted as a default assumption that No-Observed-Adverse-Effect Levels (NOAELs) or Lowest-Observed-Adverse-Effect Levels (LOAELs) in long-term toxicity studies are lower than in short-term ones, i.e. the toxic potency increases with prolonged exposure duration. Recent studies on pesticides and industrial chemicals reported that subacute, subchronic or chronic NOAELs/LOAELs are similar when study design factors are appropriately considered. We investigated whether these findings also apply to certain food constituents. After reviewing subchronic and chronic toxicity studies on more than 100 compounds, a total of 32 compounds could be included in the analysis. Geometric mean (GM) values of subchronic vs. chronic NOAEL or LOAEL ratios ranged from 1.0 to 2.0, with a geometric standard deviation from 2.2 to 4.2, which is consistent with data reported in the literature. While for many of the investigated compounds the ratio is around 1 – suggesting that health-based guidance values could appropriately be derived from subchronic toxicity studies – our study also identified some substances with higher ratios leading to a GM of around 2. The EFSA Scientific Committee suggested to apply an uncertainty factor of 2 to extrapolate from subchronic to chronic studies and, as a precautionary approach, we concur with this suggestion.

Highlights

  • It has been generally assumed that the toxic potency increases with increasing exposure duration and that, No-ObservedAdverse-Effect Levels (NOAELs) or Lowest-Observed-Adverse-Effect Levels (LOAELs) derived from long-term toxicity studies (NOAELc/LOAELc) are lower than No-Observed-Adverse-Effect Level (NOAEL)/LowestObserved-Adverse-Effect Levels (LOAELs) derived from shortterm toxicity studies (NOAELsa/LOAELsa, NOAELsc/LOAELsc)

  • It has been generally assumed that the toxic potency increases with increasing exposure duration and that, No-ObservedAdverse-Effect Levels (NOAELs) or Lowest-Observed-Adverse-Effect Levels (LOAELs) derived from long-term toxicity studies (NOAELc/LOAELc) are lower than NOAELs/LOAELs derived from shortterm toxicity studies (NOAELsa/LOAELsa, NOAELsc/LOAELsc)

  • NOAELsc/NOAELc or LOAELsc/LOAELc study pairs were only identified in trials with rodents, whereas dog studies were scarce

Read more

Summary

Introduction

It has been generally assumed that the toxic potency increases with increasing exposure duration and that, No-ObservedAdverse-Effect Levels (NOAELs) or Lowest-Observed-Adverse-Effect Levels (LOAELs) derived from long-term (chronic) toxicity studies (NOAELc/LOAELc) are lower than NOAELs/LOAELs derived from shortterm (subacute, subchronic) toxicity studies (NOAELsa/LOAELsa, NOAELsc/LOAELsc). The European Food Safety Au­ thority (EFSA) Scientific Committee concluded that the extrapolation from a subchronic to a chronic study duration may be performed by application of an uncertainty factor of 2, provided that the 90-day study used to extrapolate is of adequate quality (e.g. similar parameters were investigated as usually carried out in chronic studies) (EFSA, 2012b). The EFSA Scientific Committee was not in a position to propose default values to extrapolate from a subacute to a chronic study duration because there was less confidence that toxic effects identified in 90-day or chronic studies would be detected in studies of shorter duration (EFSA, 2012b). It was recommended to consider an extrap­ olation from a subacute to a chronic study duration on a case-by-case basis (EFSA, 2012b)

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.